Two Sigma Investments
PDSB icon

Two Sigma Investments’s PDS Biotechnology PDSB Stock Holding History

Two Sigma Investments’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-65,732
Closed -$107K – 3422
2024
Q4 		$107K Buy
65,732
+48,132
+273% +$127K ﹤0.01% 2965
2024
Q3 		$67.2K Hold
17,600
– – ﹤0.01% 2946
2024
Q2 		$51.6K Buy
+17,600
New +$56.3K ﹤0.01% 2883
2024
Q1 		– Sell
-40,576
Closed -$202K – 3286
2023
Q4 		$202K Sell
40,576
-87,019
-68% -$433K ﹤0.01% 2835
2023
Q3 		$644K Sell
127,595
-106,551
-46% -$584K ﹤0.01% 2164
2023
Q2 		$1.18M Sell
234,146
-354,904
-60% -$2.32M ﹤0.01% 1852
2023
Q1 		$3.62M Buy
589,050
+92,581
+19% +$757K 0.01% 1059
2022
Q4 		$6.55M Buy
496,469
+198,257
+66% +$1.4M 0.02% 728
2022
Q3 		$886K Sell
298,212
-143,299
-32% -$608K ﹤0.01% 1517
2022
Q2 		$1.61M Buy
441,511
+17,940
+4% +$85.3K 0.01% 1312
2022
Q1 		$2.62M Sell
423,571
-58,595
-12% -$364K 0.01% 1214
2021
Q4 		$3.91M Buy
482,166
+101,424
+27% +$1.09M 0.01% 1348
2021
Q3 		$5.67M Buy
380,742
+311,635
+451% +$3.89M 0.01% 1140
2021
Q2 		$867K Buy
+69,107
New +$540K ﹤0.01% 2603
2021
Q1 		– Sell
-11,290
Closed -$24K – 4157
2020
Q4 		$24K Buy
+11,290
New +$24.7K ﹤0.01% 3271
2019
Q1 		– Sell
-11,852
Closed -$76K – 3373
2018
Q4 		$76K Sell
11,852
-1,527
-11% -$20.2K ﹤0.01% 2838
2018
Q3 		$219K Buy
13,379
+7
+0.1% +$126 ﹤0.01% 2954
2018
Q2 		$275K Buy
13,372
+11,750
+724% +$245K ﹤0.01% 2993
2018
Q1 		$38K Buy
+1,622
New +$436K ﹤0.01% 3071

Other funds holding PDSB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return

Two Sigma Investments's PDSB Position: Q1 2025 in Review

Two Sigma Investments sold out of PDS Biotechnology (PDSB) in Q1 2025, closing a stake of 65,732 shares — an estimated $107K sold.

Two Sigma Investments first reported a position in PDSB in Q1 2018 and held it in 19 quarters. The position peaked at $6.55M in Q4 2022. 48 funds tracked by Wall St. Rank hold PDSB as of Q1 2025.

  • Two Sigma Investments reported no remaining PDS Biotechnology position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Investments sold 65,732 PDS Biotechnology shares in Q1 2025, an estimated $107K.
  • Two Sigma Investments first reported a position in PDS Biotechnology in Q1 2018 and held it in 19 quarters.
  • Two Sigma Investments's PDS Biotechnology position peaked at $6.55M in Q4 2022.
  • 48 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2025.

Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.